Pharma giant Biocon plunges over 9% after inspecting authority found lapses at Bengaluru plant
DSIJ Intelligence / 10 Jul 2017
Biocon, the Indian bio pharmaceutical giant, plunged over 9% in Monday’s trade on the BSE as the French inspecting authority (ANSM) found lapses at Biocon's Bengaluru plant.
Biocon, the Indian bio pharmaceutical giant, plunged over 9% in Monday’s trade on the BSE as the French inspecting authority (ANSM) found lapses at Biocon's Bengaluru plant.
the Biocon's Bengaluru plant was inspected by ANSM on behalf of the European Medicine Agency (EMA).
ANSM notified Biocon that the receipt of a GMP compliance certificate for the drug product facility will require a follow-up inspection from ANSM to verify implementation of the proposed corrective and preventive actions, said Biocon in a BSE filing on Sunday.
Biocon and its partner Mylan, will work with the French and European regulatory authorities with regard to the follow-up inspection of the drug product facility and the marketing authorisation applications with the goal of an early re-inspection, informed Biocon.
Biocon was trading at Rs 319.70, down by Rs 17.35 or 5.15% as at 1153 hours on Monday, on the BSE.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.